SCHEMBL9724497

SCHEMBL9724497

C=CCCN(C)N1c2ccccc2Sc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.47
CYP2D6 P10635 4/20 0.45
SIGMAR1 Q99720 4/20 0.45
CHRM2 P08172 3/20 0.45
HTR1A P08908 3/20 0.45
ADRA2A P08913 3/20 0.45
CHRM1 P11229 3/20 0.45
DRD1 P21728 3/20 0.45
SLC6A2 P23975 3/20 0.45
SLC6A4 P31645 3/20 0.45
ADRA1A P35348 3/20 0.45
OPRM1 P35372 3/20 0.45
DRD3 P35462 3/20 0.45
KCNH2 Q12809 3/20 0.45
SLC22A1 O15245 2/20 0.45
PRNP P04156 2/20 0.45
CYP1A2 P05177 2/20 0.45
CHRM4 P08173 2/20 0.45
CHRM5 P08912 2/20 0.45
DRD2 P14416 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5865535 0.73 KMT2A (0.45) KDM1ACYP2D6SIGMAR1CHRM2HTR1A
SCHEMBL8095239 0.72 MAOA (0.58) KDM1ACYP2D6SIGMAR1CHRM2HTR1A
Hydrochloric Acid SCHEMBL8089788 0.70 MAOA (0.56) KDM1ACYP2D6SIGMAR1CHRM2HTR1A
SCHEMBL15553296 0.70 ITGB2 (0.59) KDM1ACYP2D6SIGMAR1CHRM2HTR1A
SCHEMBL39172 0.67 KMT2A (0.52) KDM1ACYP2D6SIGMAR1CHRM2HTR1A
SCHEMBL29376932 0.67 KMT2A (0.52) KDM1ACYP2D6SIGMAR1CHRM2HTR1A
Iodide SCHEMBL11442732 0.66 KMT2A (0.51) KDM1ACYP2D6SIGMAR1CHRM2HTR1A
SCHEMBL9724496 0.66 MAOA (0.46) KDM1ACYP2D6SIGMAR1CHRM2HTR1A
SCHEMBL15229632 0.66 BCHE (0.49) KDM1ACYP2D6SIGMAR1CHRM2HTR1A
SCHEMBL7341247 0.66 KDM1A (0.59) KDM1ACYP2D6SIGMAR1CHRM2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5104858-A Administering trans-flupenthiyol with doxorubicin; lack of antipsychotic activity reduces side effects YALE UNIVERSITY (US) 1992-04-14 US disclosed